Clin2
NCT07557355Possibly a fitNot yet recruiting

Weight loss study for people who are overweight or obese

Overweight , Obesity

Part of Hormones & metabolism clinical trials.

This study tests a new medicine, SRSD384, to see if it can help people who are overweight or obese lose weight. It is an early-stage trial, so the focus is on safety and how well the medicine works.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
78 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You must be an adult who is willing to sign a consent form and follow study rules.
  • Your body mass index (BMI) must be between 27 and 40, which is a measure of weight for height.
  • You must not donate sperm or eggs during the study and for 3 months after.
  • Your obesity must not be due to another medical condition or certain medications.
  • You must not have had cancer in the last 2 years (except for some non-serious skin cancers).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07690826Not yet recruiting· Phase 2
Weight loss injection study for adults with obesity

This study tests an investigational injection called HRS-4729 to see if it helps people with obesity lose weight. It may offer a new treatment option for those who have been trying to manage their weight with diet and exercise.

Shanghai, Shanghai Municipality
NCT07826364Not yet recruiting· Phase 1
Testing a new obesity treatment for safety and weight loss

This trial tests a new injectable medication called SHR-1179 to see if it is safe and can help with weight loss. It is a placebo-controlled study, meaning some participants receive the drug and others receive an inactive shot, and no one knows which they get.

Shanghai, Shanghai Municipality
NCT07841860Not yet recruiting· Phase 1
Weight loss study for healthy and obese adults

This study tests a new weight-loss medicine called HRS-1596. It is given as a tablet to see if it is safe and how well it works. The study first gives a single dose to healthy adults, then multiple doses to people with obesity.

Jinan, Shandong
NCT07716241Not yet recruiting· Phase 1
Study of an investigational injection for weight management in healthy or overweight adults

This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.

Hefei
NCT07467447Recruiting· Phase 2
Testing a weight-loss drug for people with obesity or overweight

This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.

Shenzhen, Guangdong
NCT07784725Recruiting· Phase 3
Study of a weight loss injection for adults with obesity

This study tests a new medicine to help adults with obesity or overweight lose weight. It's for people who have had trouble losing weight in the past and don't have diabetes.

Dothan, Alabama

Hear when a new Overweight , Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.